跳至主要内容
临床试验/EUCTR2005-001584-66-DE
EUCTR2005-001584-66-DE进行中(未招募)不适用

A randomised controlled multicentre study for the safety of Depigoid(R)rush schedule

ETI Pharma GmbH0 个研究点目标入组 320 人开始时间: 2005年7月13日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients of both gender aged from 18 up to 65 years
  • 2. Prior to study specific examinations the patient has to give his/her written in-formed consent.
  • 3. FEV1 or PEF > 70% of predicted normal value under normal conditions
  • 4. FEV1 or PEF > 80% of predicted normal value directly before injection
  • 5. The patients have to suffer from allergic complaints (rhinitis and/or rhinoconjunctivitis without uncontrolled allergic asthma) caused by clinical sensitisation against tree pollen, grass pollen or house dust mites. Polysensitised patients can also be included. The IgE mediated sensitisation has to be verified by
  • · suggestive medical history
  • · a positive skin prick test LETI for tree pollen, grass pollen or house dust mites, resulting in a wheal diameter of at least 3 mm > negative control re-action or '++' versus histamine
  • · specific IgE > 1 (CAP-RAST)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnant or lactating women
  • 2. Women of child-bearing age not employing sufficient contraceptive protection (contraceptive medication or condom)
  • 3. Participation in another clinical trial within the last 3 months prior to this study
  • 4. Smokers with a manifested bronchopathy
  • 5. Alcohol- or drug abusers
  • 6. Persons, who are obviously not compliant
  • 7. Patients, who are employees at the investigational site, relative or spouse of the investigator
  • 8. Acute and chronic inflammatory or infectious diseases (incl. target organ)
  • 9. Advanced secondary changes at the target organ (e.g. emphysema or bronchiectasis)
  • 10. Immunopathological diseases (e.g. of the liver, kidney, the nervous system, thyroid gland, rheumatic diseases) in which autoimmune mechanisms play a role
  • 11. Immune deficiencies
  • 12. Chronic asthma
  • 13. Treatment with b-blockers
  • 14. Malignancies < 5 years
  • 15. Any disease which prohibits the use of adrenaline (e. g. hyperthyroidism)
  • 16. Serious psychiatric/psychological disturbances
  • 17. Concomitant treatment with substances interfering with the immune system

研究者

发起方
ETI Pharma GmbH

相似试验

已完成
不适用
A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patientsInfluenza virus infection
JPRN-UMIN000009479agasaki evaluation organization for clinical interventions120
进行中(未招募)
1 期
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for the treatment of dermatophytic onychomycosis (toenail) without matrix involvement - ONICO
EUCTR2009-011125-14-FRPierre Fabre Dermatologie260
已完成
不适用
Internet-based relapse prevention for in-patients with anorexia nervosaSevere anorexia nervosa (AN)Mental and Behavioural DisordersEating disorders
ISRCTN18274621South London and Maudsley NHS Foundation Trust (UK)98
进行中(未招募)
3 期
Trial of sertraline to prevent post-traumatic brain injury depressioDepressive disorder after traumatic brain injuryMental and Behavioural Disorders
ISRCTN17518945King's College Hospital514
已完成
不适用
The multicenter randomized controlled trial on the effect of Helicobacter pylori eradication for endoscopic gastric submucosal dissection (ESD) after artificial ulcer healingPatients have early gastric cancer endoscopic therapeutic indications lesions and adaptation expanding lesions, are Helicobacter pylori infection including the adenoma
JPRN-UMIN000015927Aichi Medical University130
A randomised controlled multicentre study for the... | 临床试验